BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37327984)

  • 1. Mutant FUS induces chromatin reorganization in the hippocampus and alters memory processes.
    Tzeplaeff L; Seguin J; Le Gras S; Megat S; Cosquer B; Plassard D; Dieterlé S; Paiva I; Picchiarelli G; Decraene C; Alcala-Vida R; Cassel JC; Merienne K; Dupuis L; Boutillier AL
    Prog Neurobiol; 2023 Aug; 227():102483. PubMed ID: 37327984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic Homeostasis Disruption in a Novel Frontotemporal Dementia Mouse Model Expressing Cytoplasmic Fused in Sarcoma.
    Shiihashi G; Ito D; Arai I; Kobayashi Y; Hayashi K; Otsuka S; Nakajima K; Yuzaki M; Itohara S; Suzuki N
    EBioMedicine; 2017 Oct; 24():102-115. PubMed ID: 28928015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive splicing changes in an ALS/FTD transgenic mouse model overexpressing cytoplasmic fused in sarcoma.
    Ito D; Taguchi R; Deguchi M; Ogasawara H; Inoue E
    Sci Rep; 2020 Mar; 10(1):4857. PubMed ID: 32184412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
    López-Erauskin J; Tadokoro T; Baughn MW; Myers B; McAlonis-Downes M; Chillon-Marinas C; Asiaban JN; Artates J; Bui AT; Vetto AP; Lee SK; Le AV; Sun Y; Jambeau M; Boubaker J; Swing D; Qiu J; Hicks GG; Ouyang Z; Fu XD; Tessarollo L; Ling SC; Parone PA; Shaw CE; Marsala M; Lagier-Tourenne C; Cleveland DW; Da Cruz S
    Neuron; 2018 Nov; 100(4):816-830.e7. PubMed ID: 30344044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin A Relieves Growth Suppression and Restores Histone Acetylation at Specific Sites in a FUS ALS/FTD Yeast Model.
    Bennett SA; Cobos SN; Mirzakandova M; Fallah M; Son E; Angelakakis G; Rana N; Hugais M; Torrente MP
    Biochemistry; 2021 Dec; 60(48):3671-3675. PubMed ID: 34788013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Huang C; Zhou H; Tong J; Chen H; Liu YJ; Wang D; Wei X; Xia XG
    PLoS Genet; 2011 Mar; 7(3):e1002011. PubMed ID: 21408206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
    Nolan M; Talbot K; Ansorge O
    Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation.
    Sanjuan-Ruiz I; Govea-Perez N; McAlonis-Downes M; Dieterle S; Megat S; Dirrig-Grosch S; Picchiarelli G; Piol D; Zhu Q; Myers B; Lee CZ; Cleveland DW; Lagier-Tourenne C; Da Cruz S; Dupuis L
    Mol Neurodegener; 2021 Sep; 16(1):61. PubMed ID: 34488813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.
    Yamaguchi A; Takanashi K
    Sci Rep; 2016 Oct; 6():35195. PubMed ID: 27731383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear RNA transcript levels modulate nucleocytoplasmic distribution of ALS/FTD-associated protein FUS.
    Tsai YL; Mu YC; Manley JL
    Sci Rep; 2022 May; 12(1):8180. PubMed ID: 35581240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis.
    Oyston LJ; Ubiparipovic S; Fitzpatrick L; Hallupp M; Boccanfuso LM; Kwok JB; Dobson-Stone C
    Sci Rep; 2021 Jul; 11(1):14881. PubMed ID: 34290285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits.
    Ho WY; Agrawal I; Tyan SH; Sanford E; Chang WT; Lim K; Ong J; Tan BSY; Moe AAK; Yu R; Wong P; Tucker-Kellogg G; Koo E; Chuang KH; Ling SC
    Acta Neuropathol Commun; 2021 Jan; 9(1):9. PubMed ID: 33407930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS.
    Arenas A; Chen J; Kuang L; Barnett KR; Kasarskis EJ; Gal J; Zhu H
    Hum Mol Genet; 2020 Sep; 29(16):2684-2697. PubMed ID: 32691043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
    Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
    Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUS-mediated dysregulation of Sema5a, an autism-related gene, in FUS mice with hippocampus-dependent cognitive deficits.
    Ho WY; Chang JC; Tyan SH; Yen YC; Lim K; Tan BSY; Ong J; Tucker-Kellogg G; Wong P; Koo E; Ling SC
    Hum Mol Genet; 2019 Nov; 28(22):3777-3791. PubMed ID: 31509188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
    Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
    Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled FUS binds active chromatin and regulates gene transcription.
    Yang L; Gal J; Chen J; Zhu H
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17809-14. PubMed ID: 25453086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.